ARCHIVES

PhRMA Offers Assistance For Part D “Doughnut Hole”

This article is from The Cancer Letter archive.

Vol. 35 No. 25 | June 26, 2009

Download PDF Visit The Full Archive

Related Articles

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

October 25, 2013

NCI Initiatives: Advisors Approves AIDS, Minority Training Programs

December 13, 1996

Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer

April 24, 2009

Guidelines Adopted For Pathology Review

February 22, 1980

In Brief: Kea, Montes Leave DCPC; Smart Heads Early Detection Branch; Costlow Special Assistant

October 3, 1986

Six Compounds Carcinogenic, Risk to Humans, CH Subgroup Finds

February 2, 1979